For: | Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 2005; 11(3): 331-335 [PMID: 15637738 DOI: 10.3748/wjg.v11.i3.331] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/331.htm |
Number | Citing Articles |
1 |
Elias Zintzaras. Glutathione S-Transferase M1 and T1 Genes and Susceptibility to Chronic Myeloid Leukemia: A Meta-Analysis. Genetic Testing and Molecular Biomarkers 2009; 13(6): 791 doi: 10.1089/gtmb.2009.0079
|
2 |
Hoirun Nisa, Suminori Kono, Guang Yin, Kengo Toyomura, Jun Nagano, Ryuichi Mibu, Masao Tanaka, Yoshihiro Kakeji, Yoshihiko Maehara, Takeshi Okamura, Koji Ikejiri, Kitaroh Futami, Takafumi Maekawa, Yohichi Yasunami, Kenji Takenaka, Hitoshi Ichimiya, Reiji Terasaka. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-274
|
3 |
Yong Gao, Xiaofen Pan, Ting Su, Zengnan Mo, Yunfei Cao, Feng Gao. Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: A meta-analysis and HuGE review. European Journal of Cancer 2009; 45(18): 3303 doi: 10.1016/j.ejca.2009.06.029
|
4 |
Mariko Naito, Yasuyuki Goto, Yoshiko Ishida, Kazuko Nishio, Sayo Kawai, Nobuyuki Hamajima. Alternative genotyping method ofGSTT1null/present polymorphism. Expert Review of Molecular Diagnostics 2006; 6(6): 873 doi: 10.1586/14737159.6.6.873
|
5 |
I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger, T Hudson, T Koessler, P D Pharoah, I Niittymäkix, S Tuupanenx, L A Aaltonen, K Hemminki, A Lindblom, A Försti, O Sieber, L Lipton, T van Wezel, H Morreau, J T Wijnen, P Devilee, K Matsuda, Y Nakamura, S Castellví-Bel, C Ruiz-Ponte, A Castells, A Carracedo, J W C Ho, P Sham, R M W Hofstra, P Vodicka, H Brenner, J Hampe, C Schafmayer, J Tepel, S Schreiber, H Völzke, M M Lerch, C A Schmidt, S Buch, V Moreno, C M Villanueva, P Peterlongo, P Radice, M M Echeverry, A Velez, L Carvajal-Carmona, R Scott, S Penegar, P Broderick, A Tenesa, R S Houlston. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British Journal of Cancer 2010; 102(2): 447 doi: 10.1038/sj.bjc.6605338
|
6 |
Iain Beehuat Tan, Joanne Ngeow, Patrick Tan. Encyclopedia of Life Sciences. 2010; doi: 10.1002/9780470015902.a0022403
|
7 |
Steven J. Hawken, Celia M. T. Greenwood, Thomas J. Hudson, Rafal Kustra, John McLaughlin, Quanhe Yang, Brent W. Zanke, Julian Little. The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Human Genetics 2010; 128(1): 89 doi: 10.1007/s00439-010-0828-1
|
8 |
Steffen Pistorius, Heike Goergens, Christoph Engel, Jens Plaschke, Stefan Krueger, Ruth Hoehl, Hans-Detlev Saeger, Hans K. Schackert. N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer. International Journal of Colorectal Disease 2006; 22(2): 137 doi: 10.1007/s00384-006-0171-0
|
9 |
Lauren A. Trepanier. Advances in Bioactivation Research. 2008; : 1 doi: 10.1007/978-0-387-77300-1_16
|
10 |
Alessio Naccarati, Barbara Pardini, Kari Hemminki, Pavel Vodicka. Sporadic colorectal cancer and individual susceptibility: A review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutation Research/Reviews in Mutation Research 2007; 635(2-3): 118 doi: 10.1016/j.mrrev.2007.02.001
|
11 |
Bin Li, Jian Zhang, Lei Wang, Yan Li, Juping Jin, Limei Ai, Chong Li, Zhe Li, Shudan Mao. MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies. Tumor Biology 2014; 35(5): 4233 doi: 10.1007/s13277-013-1554-9
|
12 |
Eckart Schnakenberg, Karl-Rainer Fabig, Martin Stanulla, Nils Strobl, Michael Lustig, Nathalie Fabig, Werner Schloot. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes. Environmental Health 2007; 6(1) doi: 10.1186/1476-069X-6-6
|
13 |
D F Carr, G Whiteley, A Alfirevic, M Pirmohamed. Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. The Pharmacogenomics Journal 2009; 9(5): 291 doi: 10.1038/tpj.2009.29
|
14 |
Konstantinos P. Economopoulos, Theodoros N. Sergentanis. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis. European Journal of Cancer 2010; 46(9): 1617 doi: 10.1016/j.ejca.2010.02.009
|
15 |
Georgia M. Beasley, Zhifei Sun, Daniel P. Nussbaum, Douglas S. Tyler. Holland‐Frei Cancer Medicine. 2017; : 1 doi: 10.1002/9781119000822.hfcm095
|
16 |
Elias Zintzaras. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. Journal of Human Genetics 2006; 51(7): 618 doi: 10.1007/s10038-006-0405-6
|
17 |
Guanglong Dong, Xianli He, Yibing Chen, Haiyan Cao, Jiaojiao Wang, Xiaonan Liu, Shukui Wang, Shaogui Wan, Jinliang Xing. Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0442-x
|
18 |
S. D. Ramsey, R. S. Holmes, C. L. McDermott, D. K. Blough, K. L. Petrin, E. M. Poole, C. M. Ulrich. A comparison of approaches for association studies of polymorphisms and colorectal cancer risk. Colorectal Disease 2012; 14(9) doi: 10.1111/j.1463-1318.2012.03021.x
|
19 |
Hyeong Sang Kim, Sun Jin Hur. Changes in the mutagenicity of heterocyclic amines, nitrite, and N-nitroso compound in pork patties during in vitro human digestion. LWT 2018; 92: 47 doi: 10.1016/j.lwt.2018.01.079
|
20 |
E. Theodoratou, Z. Montazeri, S. Hawken, G. C. Allum, J. Gong, V. Tait, I. Kirac, M. Tazari, S. M. Farrington, A. Demarsh, L. Zgaga, D. Landry, H. E. Benson, S. H. Read, I. Rudan, A. Tenesa, M. G. Dunlop, H. Campbell, J. Little. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer. JNCI Journal of the National Cancer Institute 2012; 104(19): 1433 doi: 10.1093/jnci/djs369
|
21 |
Mariano Sánchez-Siles, Juan Pablo Pelegrín-Hernández, Diego Hellin-Meseguer, Yolanda Guerrero-Sánchez, Andrés Corno-Caparrós, Juan Cabezas-Herrera, Francisco Pastor-Quirante, Juan Alberto Fernández-Ruiz, Alfonso Aliaga-Sánchez, Mayra Lucero-Berdugo, Fabio Camacho-Alonso. Genotype of Null Polymorphisms in Genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)/CYP1A1*2C (rs1048943 A>G) in Patients with Larynx Cancer in Southeast Spain. Cancers 2020; 12(9): 2478 doi: 10.3390/cancers12092478
|
22 |
A.L.S. Galbiatti, M.T. Ruiz, P.M. Biselli-Chicote, L.S. Raposo, J.V. Maniglia, E.C. Pavarino-Bertelli, E.M. Goloni-Bertollo. 5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer. Brazilian Journal of Medical and Biological Research 2010; 43(5): 445 doi: 10.1590/S0100-879X2010007500034
|
23 |
K Vinod Kumar, Anitha Goturi, M Nagaraj, EV Soma Sekhar Goud. Null genotypes of Glutathione S-transferase M1 and T1 and risk of oral cancer. Journal of Oral and Maxillofacial Pathology 2022; 26(4): 592 doi: 10.4103/jomfp.jomfp_435_21
|
24 |
Raquel L.F. Teixeira, Floriano P. Silva, Aline R. Silveira, Pedro H. Cabello, Leila Mendonça-Lima, Marcelo F. Rabahi, Afrânio L. Kritski, Fernanda C.Q. Mello, Philip N. Suffys, Antonio B. de Miranda, Adalberto R. Santos. Sequence analysis of NAT2 gene in Brazilians: Identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010; 683(1-2): 43 doi: 10.1016/j.mrfmmm.2009.10.009
|
25 |
Monir Sadat Haerian, Batoul Sadat Haerian, Saadat Molanaei, Farid Kosari, Shahram Sabeti, Farahnaz Bidari-Zerehpoosh, Ebrahim Abdolali, Mohammad Reza Zali.
MTHFR
rs1801133 Polymorphism and Susceptibility to Colorectal Cancer in Iranian Population: Evidence of a Case–Control Study and Meta-Analysis
. Pharmacogenomics 2016; 17(17): 1957 doi: 10.2217/pgs-2016-0048
|
26 |
Mala Pande, Christopher I. Amos, Daniel R. Osterwisch, Jinyun Chen, Patrick M. Lynch, Russell Broaddus, Marsha L. Frazier. Genetic Variation in Genes for the Xenobiotic-Metabolizing EnzymesCYP1A1, EPHX1, GSTM1, GSTT1, andGSTP1and Susceptibility to Colorectal Cancer in Lynch Syndrome. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(9): 2393 doi: 10.1158/1055-9965.EPI-08-0326
|
27 |
Xu Zhong, Cao Hui, Wu Xiao-Ling, Li Yan, Luo Na. NAT2 Polymorphism and Gastric Cancer Susceptibility: A Meta-analysis. Archives of Medical Research 2010; 41(4): 275 doi: 10.1016/j.arcmed.2010.06.001
|
28 |
N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Letters 2006; 241(1): 150 doi: 10.1016/j.canlet.2005.10.018
|
29 |
Xueru Zhu, Zhao Wang, Jing He, Weiye Wang, Wenji Xue, Yiwei Wang, Leizhen Zheng, Mei-Ling Zhu. Associations betweenCYP1A1rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies. Oncotarget 2016; 7(32): 51365 doi: 10.18632/oncotarget.10331
|
30 |
Xin-Jiang Ying, Pin Dong, Bin Shen, Jie Wang, Sang Wang, Guo Wang. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. Journal of Cancer Research and Clinical Oncology 2011; 137(11): 1661 doi: 10.1007/s00432-011-1045-6
|
31 |
Yong Gao, Yunfei Cao, Aihua Tan, Cun Liao, Zengnan Mo, Feng Gao. Glutathione S–Transferase M1 Polymorphism and Sporadic Colorectal Cancer Risk: An Updating Meta-Analysis and HuGE Review of 36 Case-Control Studies. Annals of Epidemiology 2010; 20(2): 108 doi: 10.1016/j.annepidem.2009.10.003
|
32 |
Robin L. Williams, Kyle B. Williams. Reference Module in Biomedical Sciences. 2024; doi: 10.1016/B978-0-323-95488-4.00196-0
|
33 |
Klaus Golka, Hermann C. Roemer, Wobbeke Weistenhöfer, Meinolf Blaszkewicz, Seddik Hammad, Thomas Reckwitz, Dietrich Loehlein, Mark Hartel, Jan G. Hengstler, Frank Geller. N-Acetyltransferase 2 and GlutathioneS-Transferase M1 in Colon and Rectal Cancer Cases from an Industrialized Area. Journal of Toxicology and Environmental Health, Part A 2012; 75(8-10): 572 doi: 10.1080/15287394.2012.675310
|
34 |
Cun Liao, Yunfei Cao, Liucheng Wu, Jiahao Huang, Feng Gao. An updating meta-analysis of the glutathione S-transferase T1 polymorphisms and colorectal cancer risk: a HuGE review. International Journal of Colorectal Disease 2010; 25(1): 25 doi: 10.1007/s00384-009-0805-0
|
35 |
Neville J. Butcher, Rodney F. Minchin. Arylamine N-Acetyltransferase 1: A Novel Drug Target in Cancer Development. Pharmacological Reviews 2012; 64(1): 147 doi: 10.1124/pr.110.004275
|
36 |
Jeppe Zacho, Shiva Yazdanyar, Stig E. Bojesen, Anne Tybjærg‐Hansen, Børge G. Nordestgaard. Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: Cross‐sectional and prospective studies and meta‐analyses of 75,000 cases and 93,000 controls. International Journal of Cancer 2011; 128(3): 644 doi: 10.1002/ijc.25375
|
37 |
B. Pardini, A. Naccarati, P. Vodicka, R. Kumar. Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk. Mutagenesis 2012; 27(2): 161 doi: 10.1093/mutage/ger057
|
38 |
H. Norppa, S. Bonassi, I.-L. Hansteen, L. Hagmar, U. Strömberg, P. Rössner, P. Boffetta, C. Lindholm, S. Gundy, J. Lazutka, A. Cebulska-Wasilewska, E. Fabiánová, R.J. Šrám, L.E. Knudsen, R. Barale, A. Fucic. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006; 600(1-2): 37 doi: 10.1016/j.mrfmmm.2006.05.030
|
39 |
Carmen Martínez, Felipe Martín, Juana M Fernández, Elena García-Martín, Javier Sastre, Manuel Díaz-Rubio, José AG Agúndez, José M Ladero.
Glutathione
S
-Transferases μ1, θ1, π1, α1 and μ3 Genetic Polymorphisms and the risk of Colorectal and Gastric Cancers in Humans
. Pharmacogenomics 2006; 7(5): 711 doi: 10.2217/14622416.7.5.711
|
40 |
Carmen S. P. Lima, Helvia Nascimento, Luciana C. Bonadia, Maria T. Teori, Claudio S. R. Coy, Juvenal R. N. Góes, Fernando F. Costa, Carmen S. Bertuzzo. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. International Journal of Colorectal Disease 2007; 22(7) doi: 10.1007/s00384-006-0237-z
|
41 |
David Hein, Jason Moore, La Creis Renee Kidd, Robert Martin. Nutrient-Gene Interactions in Cancer. 2006; : 189 doi: 10.1201/9781420004847.ch10
|
42 |
|
43 |
Guillermo Gervasini, Elena García-Martín, José M Ladero, Rosa Pizarro, Javier Sastre, Carmen Martínez, Monserrat García, Manuel Diaz-Rubio, José AG Agúndez. Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-118
|
44 |
Xianlu Zhuo, Lei Cai, Zhaolan Xiang, Qi Li, Xueyuan Zhang. GSTMI and GSTTI polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. Journal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-46
|
45 |
Jane C. Figueiredo, A. Joan Levine, Jimmy W. Crott, James Baurley, Robert W. Haile. Folate‐genetics and colorectal neoplasia: What we know and need to know next. Molecular Nutrition & Food Research 2013; 57(4): 607 doi: 10.1002/mnfr.201200278
|
46 |
Yota Suzuki, Douglas S. Tyler, Uma R. Phatak. Holland‐Frei Cancer Medicine. 2022; : 1 doi: 10.1002/9781119000822.hfcm144
|
47 |
J.M. Angel, E.L. Abel, J. DiGiovanni. Comprehensive Toxicology. 2010; : 371 doi: 10.1016/B978-0-08-046884-6.01419-6
|
48 |
Lynn M. Bekris, Cindy Shephard, Morgan Peterson, Jana Hoehna, Brian Van Yserloo, Elizabeth Rutledge, Federico Farin, Terrance J. Kavanagh, Ake Lernmark. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 2005; 38(8): 567 doi: 10.1080/08916930500407238
|
49 |
K. Bendjemana, H. Douik, Y. Hamada, A. Fercha, A. Bouakkaz, S. Habibatni, Y. Kadri, F. Guemira, M. Abdennebi, D. Satta. GSTM1 and GSTT1 polymorphisms, tobacco use as risk factors for nasopharyngeal carcinoma in maghreb population — A case-control study. Journal Africain du Cancer / African Journal of Cancer 2014; 6(1): 11 doi: 10.1007/s12558-013-0289-2
|
50 |
Alba Hernández, Noel Xamena, Sara Gutiérrez, Antonia Velázquez, Amadeu Creus, Jordi Surrallés, Pere Galofré, Ricardo Marcos. Basal and induced micronucleus frequencies in human lymphocytes with different GST and NAT2 genetic backgrounds. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2006; 606(1-2): 12 doi: 10.1016/j.mrgentox.2006.02.002
|
51 |
J.M. Angel, J. DiGiovanni. Comprehensive Toxicology. 2018; : 330 doi: 10.1016/B978-0-12-801238-3.65251-0
|
52 |
Xin-Jiang Ying, Cheng-Zhi Xu, Hong-Ming Xu, Zhen-Feng Sun, Jia Zhang, Guo-Liang Wang, Pin Dong. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: A meta-analysis based on 2,124 cases and 2,059 controls. Gene 2012; 494(1): 11 doi: 10.1016/j.gene.2011.12.014
|
53 |
Dan Wang, Li-Mei Zhang, Jun-Xia Zhai, Dian-Wu Liu. GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: a meta-analysis. International Journal of Colorectal Disease 2012; 27(7): 901 doi: 10.1007/s00384-011-1406-2
|
54 |
Ute Nöthlings, Jennifer F. Yamamoto, Lynne R. Wilkens, Suzanne P. Murphy, Song-Yi Park, Brian E. Henderson, Laurence N. Kolonel, Loïc Le Marchand. Meat and Heterocyclic Amine Intake, Smoking, NAT1 and NAT2 Polymorphisms, and Colorectal Cancer Risk in the Multiethnic Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 2009; 18(7): 2098 doi: 10.1158/1055-9965.EPI-08-1218
|
55 |
Hongwei Wan, Yong Zhou, Ping Yang, Bo Chen, Guiqing Jia, Xiaoting Wu. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis. Cancer Epidemiology 2010; 34(1): 66 doi: 10.1016/j.canep.2009.12.006
|
56 |
Viktor Komlósi, Erika Hitre, Éva Pap, Vilmos Adleff, Andrea Réti, Éva Székely, Anna Bíró, Péter Rudnai, Bernadette Schoket, Judit Müller, Béla Tóth, Szabolcs Ottó, Miklós Kásler, Judit Kralovánszky, Barna Budai. SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-525
|
57 |
Jolantha Beyerle, Eva Frei, Marie Stiborova, Nina Habermann, Cornelia M. Ulrich. Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. Drug Metabolism Reviews 2015; 47(2): 199 doi: 10.3109/03602532.2014.996649
|
58 |
P.V. Pereira Serafim, I.D. Cotrim Guerreiro da Silva, N. Manoukian Forones. Relationship between Genetic Polymorphism of CYP1A1 at Codon 462 (Ile462Val) in Colorectal Cancer. The International Journal of Biological Markers 2008; 23(1): 18 doi: 10.1177/172460080802300103
|